Hims & Hers' “Sick of the System” spot not only generated the highest engagement of all pharma-related ads that aired during ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...

Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...

(Reuters) - Pfizer (NYSE:PFE) has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to boost the pipeline of Black, Latino and Native ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... “Difficult to answer because as we learned last time, I mean, Donald Trump is not a predictable president, great ...

“Difficult to answer because as we learned last time, I mean, Donald Trump is not a predictable ... some good news on the Seagen acquisition.” Pfizer (NYSE:PFE) focuses on the discovery ...